STRIDES PHARMA SCIENCE
Back to Income Statement
|
STRIDES PHARMA SCIENCE Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹556 Cr | ₹3,593 Cr | ₹-71 Cr | ₹-203 Cr | ₹-460 Cr |
What is the latest Consolidated Net Profit of STRIDES PHARMA SCIENCE ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹556 Cr |
| Mar2025 | ₹3,593 Cr |
| Mar2024 | ₹-71 Cr |
| Mar2023 | ₹-203 Cr |
| Mar2022 | ₹-460 Cr |
How is Consolidated Net Profit of STRIDES PHARMA SCIENCE Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹556 Cr | -84.52 | |
| Mar2025 | ₹3,593 Cr | Positive | |
| Mar2024 | ₹-71 Cr | Negative | |
| Mar2023 | ₹-203 Cr | Negative | |
| Mar2022 | ₹-460 Cr | - | |
Compare Consolidated Net Profit of peers of STRIDES PHARMA SCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| STRIDES PHARMA SCIENCE | ₹9,395.2 Cr | -3.7% | -8.3% | 15.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
STRIDES PHARMA SCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| STRIDES PHARMA SCIENCE | -3.7% |
-8.3% |
15.5% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses